Wave Life Sciences Ltd. (WVE)
5.78
+0.08
(+1.40%)
USD |
NASDAQ |
Jun 09, 16:00
5.77
-0.01
(-0.17%)
After-Hours: 06:37
Wave Life Sciences EPS Diluted (Quarterly) : -0.1303 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novo Nordisk A/S | 1.709 |
| Filana Therapeutics, Inc. | -0.2139 |
| CorMedix, Inc. | 0.4151 |
| Eloxx Pharmaceuticals, Inc. | -0.8566 |
| Cannabis Global, Inc. | 0.00 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.09M |
| Revenue (Quarterly) | 38.25M |
| Total Expenses (Quarterly) | 64.33M |
| Enterprise Value | 582.84M |
| Gross Profit Margin (Quarterly) | 93.97% |
| Profit Margin (Quarterly) | -68.21% |
| Earnings Yield | -18.24% |
| Normalized Earnings Yield | -18.24 |